Home / Program / Main Program / Symposium 19
Symposium 19:TB in Elder and Children

Elders and children are the high-risk groups of tuberculosis infection that are underrepresented in most clinical trials and, as a result, leads to limited evidence in guideline development. Both elders and children have unique pharmacokinetics/pharmacodynamics and face different diagnostic and therapeutic challenges, compared to adult tuberculosis patients. To achieve the END TB targets set by WHO and hampered by COVID pandemic, more efforts should be made to improve programmatic management of these two vulnerable groups –– from case finding to treatment provision that is tailored to local TB epidemiology, resources and patients’ needs. This symposium aims to highlight some of the practical issues encountered by elders and children with TB, as well as health care workers, to expand programmatic capacity and quality of care for those who are too often neglected.

Date: Sunday, April 28, 2023 | Time: 15:00-16:30 (GMT+8)
Topic Speaker Country / Region
15:00-15:30 Closing the gap: advances in laboratory diagnosis of tuberculosis in children using non-sputum specimens Prof. Rina Triasih Indonesia
15:30-16:00 What is new: updates on child-friendly formulations for drug-susceptible and drug-resistant tuberculosis Prof. Ben Marais Australia
16:00-16:30 Unmet needs of elder TB patients: from screening, treatment, comorbidity management to palliative care Prof. Jen-Hau Chen Taiwan